Patent ID: 8288429

Claim:
A compound of formula (I) with the stereogenic centers in (1S,3S,5S)-configuration wherein A represents aryl or heterocyclyl, wherein the aryl or heterocyclyl is unsubstituted or independently mono- or disubstituted, wherein the substituents are independently selected from the group consisting of (C 1-4 )alkyl, (C 3-6 )cycloalkyl, (C 2-6 )alkinyl, (C 1-4 )alkoxy, NR 2 R 3 , halogen and unsubstituted or independently mono- or disubstituted phenyl, wherein the substituents are independently selected from the group consisting of (C 1-4 ) alkyl, (C 1-4 )alkoxy, fluorine and chlorine; B represents an aryl- or heterocyclyl-group, wherein the aryl or heterocyclyl is unsubstituted or independently mono-, di-, or trisubstituted, wherein the substituents are independently selected from the group consisting of (C 1-4 )alkyl, (C 1-4 )alkoxy, trifluoromethyl, NR 2 R 3 , NHC(O)CH 3 and halogen; R 1 represents aryl or heterocyclyl, wherein the aryl or heterocyclyl is unsubstituted or independently mono-, di-, or trisubstituted wherein the substituents are independently selected from the group consisting of (C 1-4 )alkyl, (C 1-4 )alkoxy, halogen, trifluoromethyl and NR 2 R 3 ; or R 1 represents a 2,3-dihydro-benzofuranyl- or a 2,3-dihydro-benzo[1,4]dioxinyl-group which groups are unsubstituted or independently mono- or disubstituted with (C 1-4 )alkyl, (C 1-4 )alkoxy and halogen; R 2 represents hydrogen or (C 1-4 )alkyl; R 3 represents hydrogen or (C 1-4 )alkyl; or a pharmaceutically acceptable salt thereof.